News: Press Release

The 2022 Indonesian Nutritional Status Survey (SSGI) shows that the national prevalence of stunting has decreased to by 2.8% to 21.6% compared to the previous year. Dexa Group collaborates with the National Population and Family Planning Board (BKKBN), the Indonesian National Police (Polri), and the Regional Government (Pemda) of Wonosobo…

Dexa Group in collaboration with the Local Government (pemda) of Wonosobo Regency and the Indonesian National Police (Polri), held social services in the form of free health checks and medical treatment and the inauguration of communal latrines. This social service is intended to support and improve the health of the…

Amidst the rising trend of COVID-19, the Indonesian government predicts the number of travelers this year will increase by 50% compared to last year. Dexa Medica, as the national pharmaceutical research company, supports the health and well-being of travelers through the "Mudik Bareng Stimuno" campaign by distributing free vitamins, supplements,…

Dexa Group partnered with the National Population and Family Planning Agency (BKKBN) RI to host an Exclusive Nursing and Education program for pregnant women and breastfeeding mothers in Brebes Regency during the First 1,000 Days of Life. This program was carried out as a joint commitment to accelerate the reduction…

Following the 53rd anniversary, Dexa Group and the Indonesian Army Health Center officially opened the renovated inpatient room at the Tk II Hospital, dr. AK Gani, Palembang. Dexa Group's devotion to providing public health services and support for the National Health Insurance (JKN) program can be seen in the refurbishment…

The Indonesian government continues to encourage the resilience and independence of the healthcare industry, as imports dominate 90% of its domestic pharmaceutical raw materials and health spending. In addition, 88% of medical device transactions through electronic catalogs (e-catalogs) are imported products. Meanwhile, research and development funds are only about 0.2%…

The Indonesian Doctors Association inaugurated the erection of a monument named "Pengabdian Dokter Indonesia" to remember the services of doctors who died to preserve the lives of Indonesians while dealing with COVID-19. Dexa Group took part in the establishment and inauguration of the monument, which took place on Thursday, March…

To improve public health and handle stunting issues in South Sulawesi, Dexa Group donated Indonesian Indigenous Modern Medicines (OMAI). The OMAI donation was symbolically handed over during the OMAI Expedition at the Bangga Buatan Indonesia & Bangga Wisata Indonesia Sulawesi Selatan 2022 South Sulawesi 2022 event at Losari Beach Pavilion,…

COVID-19 confirmed cases in Indonesia have consistently increased, as of today, there are more than 230,000 active cases. The government has guaranteed the availability of antiviral medicines following the third wave of COVID-19 strikes across the country due to the Omicron variant. Then how is the availability of vitamins in…

Dexa Group, the leading pharmaceutical company from Indonesia, is ramping up its business in Southeast Asia with the launch of Glorious Dexa Singapore, Pte. Ltd. (GDS) based in Singapore. Dexa Group has exported medicines to various countries starting with Myanmar since 1993 and began exporting international standard medicines to Singapore…